...
首页> 外文期刊>Macromolecular bioscience >Design, Degradation Mechanism and Long-Term Cytotoxicity of Poly(l-lactide) and Poly(Lactide-co-E-Caprolactone) Terpolymer Film and Air-Spun Nanofiber Scaffold
【24h】

Design, Degradation Mechanism and Long-Term Cytotoxicity of Poly(l-lactide) and Poly(Lactide-co-E-Caprolactone) Terpolymer Film and Air-Spun Nanofiber Scaffold

机译:聚(l-丙交酯)和聚(丙交酯-co-E-己内酯)三元共聚物薄膜和空气纺丝纳米纤维支架的设计,降解机理和长期细胞毒性

获取原文
获取原文并翻译 | 示例
           

摘要

Degradable nanofiber scaffold is known to provide a suitable, versatile and temporary structure for tissue regeneration. However, synthetic nanofiber scaffold must be properly designed to display appropriate tissue response during the degradation process. In this context, this publication focuses on the design of a finely-tuned poly(lactide-co-E-caprolactone) terpolymer (PLCL) that may be appropriate for vascular biomaterials applications and its comparison with well-known semi-crystalline poly(l-lactide) (PLLA). The degradation mechanism of polymer film and nanofiber scaffold and endothelial cells behavior cultured with degradation products is elucidated. The results highlights benefits of using PLCL terpolymer as vascular biomaterial compared to PLLA.
机译:已知可降解的纳米纤维支架为组织再生提供合适的,多功能的和临时的结构。但是,合成纳米纤维支架必须经过适当设计,以在降解过程中表现出适当的组织反应。在这种情况下,该出版物着重设计可能适用于血管生物材料的微调聚(丙交酯-E-己内酯)三元共聚物(PLCL)的设计,并将其与著名的半结晶聚(l -丙交酯(PLLA)。阐明了聚合物膜和纳米纤维支架的降解机理以及与降解产物一起培养的内皮细胞的行为。结果表明,与PLLA相比,使用PLCL三元共聚物作为血管生物材料的优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号